Wahby S, Fashoyin-Aje L, Osgood CL, Cheng J, et al. FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third Line Treatment of Metastatic Triple-negative Breast Cancer (mTNBC). Clin Cancer Res 2020 Nov 9. pii: 1078-0432.CCR-20-3119.
PMID: 33168656